Latest filing published 10 Nov 2020 for Supernus Pharmaceuticals, INC., €55k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory S. Patrick: trading record in brief
Gregory S. Patrick is a declared insider of Supernus Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 36 filings cover trades dated from 4 May 2012 to 9 November 2020.
On the open market, the record shows 2 purchases worth €38k and 15 sales worth €9.2M. The net balance comes to €9.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 16 option exercises. Since January 2020: no purchases and 5 sales on the market.
On 10 November 2020 came the latest disclosure, an open-market sale for €105k in Supernus Pharmaceuticals, Inc. The last purchase on record was published on 15 March 2013, which is 4,987 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gregory S. Patrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$12.983.2% of flowCommon StockSEC:0001104659-20-123596:0
- 5,000 shares@ US$25.006.2% of flowCommon StockSEC:0001104659-20-123596:1
- 5,000 shares@ US$12.983.3% of flowCommon StockSEC:0001104659-20-122611:0
- 5,000 shares@ US$23.005.8% of flowCommon StockSEC:0001104659-20-122611:1
- 15,000 shares@ US$12.989.8% of flowCommon StockSEC:0001104659-20-115378:0
- 15,000 shares@ US$20.033815.1% of flowCommon StockSEC:0001104659-20-115378:1
- 1,000 shares0Common StockSEC:0001104659-20-100179:0
- 1,120 shares0Common StockSEC:0001104659-20-100179:1
- 15,000 shares@ US$12.9810.4% of flowCommon StockSEC:0001104659-20-064386:0
- 15,000 shares@ US$25.0320.1% of flowCommon StockSEC:0001104659-20-064386:1
- 15,000 shares@ US$9.137.4% of flowCommon StockSEC:0001104659-20-059729:0
- 15,000 shares@ US$23.1418.8% of flowCommon StockSEC:0001104659-20-059729:1
- 2,590 shares0Common StockSEC:0001104659-19-043393:0
- 20,000 shares@ US$41.5310.6% of flowCommon StockSEC:0001104659-19-011559:1
- 20,000 shares@ US$9.132.3% of flowCommon StockSEC:0001104659-19-011559:0
- 20,000 shares@ US$9.242.3% of flowCommon StockSEC:0001104659-18-043825:0
- 15,000 shares@ US$9.131.7% of flowCommon StockSEC:0001104659-18-043825:1
- 35,000 shares@ US$56.6324.8% of flowCommon StockSEC:0001104659-18-043825:2
- 25,000 shares@ US$5.881.1% of flowCommon StockSEC:0001104659-18-002075:0
- 20,000 shares@ US$7.901.2% of flowCommon StockSEC:0001104659-18-002075:1
- 30,000 shares@ US$9.242.0% of flowCommon StockSEC:0001104659-18-002075:2
- 50,000 shares@ US$43.5616.1% of flowCommon StockSEC:0001104659-18-002075:3
- 26,519 shares@ US$7.901.5% of flowCommon StockSEC:0001104659-17-056611:0
- 25,000 shares@ US$46.368.5% of flowCommon StockSEC:0001104659-17-056611:1
- 1,519 shares@ US$48.000.5% of flowCommon StockSEC:0001104659-17-056611:2
25 of 35 declarations
